Conversion surgery for gastric cancer patients: A review

doi:10.4251/wjgo.v10.i11.398

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 11

This Article

(330)

(312)

(0)

(25)

(2)

(9086)

(36)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Minireviews

World J Gastrointest Oncol. Nov 15, 2018; 10(11): 398-409
Published online Nov 15, 2018. doi: 10.4251/wjgo.v10.i11.398

Table 2 Overall survival and median survival time

Reference	Years	OS (rate)			MST (mo)
		CHT	CHT + surgery		CHT	CHT + surgery
			R1/R2	R0		R1/R2	R0
Nakajima et al[73], 1997	2/3-yr				4.7	6.5
Nakajima et al[73], 1997	5-yr			55.6	4.7	6.5
Yano et al[74], 2002²	2/3-yr
Yano et al[74], 2002²	5-yr
Satoh et al[75], 2012	2/3-yr		43	75¹			19.2
Satoh et al[75], 2012	5-yr						19.2
Kanda et al[76], 2012	2/3-yr		0	45.9			29
Kanda et al[76], 2012	5-yr			34.4			29
Han et al[77], 2014	2/3-yr			41.4		7.8	22.9
Han et al[77], 2014	5-yr					7.8	22.9
Kim et al[78], 2014	2/3-yr	0	0	50	8	18	37
Kim et al[78], 2014	5-yr				8	18	37
Fukuchi et al[79], 2015	2/3-yr				14	30	62
Fukuchi et al[79], 2015	5-yr	1	15	49	14	30	62
Kinoshita et al[80], 2015	2/3-yr	0	16	63.5	9.6	29.9
Kinoshita et al[80], 2015	5-yr				9.6	29.9
Sato et al[81], 2017	2/3-yr	18.7			15.7	21.7	47.9
Sato et al[81], 2017	5-yr	0	0	48.6	15.7	21.7	47.9
Einama et al[82], 2017	2/3-yr						29
Einama et al[82], 2017	5-yr						29
Mieno et al[83], 2017	2/3-yr	56.9		73.1		56.1
Mieno et al[83], 2017	5-yr					56.1
Yamaguchi et al[84], 2017	2/3-yr				11.3	21.2	41.3
Yamaguchi et al[84], 2017	5-yr				11.3	21.2	41.3
Morgagni et al[85], 2018	2/3 yr	0		39.4	14		38³
Morgagni et al[85], 2018	5 yr				14		38³

¹R0 in only pre-Cy1 patients;

²No data are specified but a P value < 0.0003 is shown between resected and not-resected 5-years OS rate;

³Patients who had cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy had an MST of 50 mo. OS: Overall survival; MST: Median survival time; CHT: Chemotherapy.

Full Size Table

Citation: Zurleni T, Gjoni E, Altomare M, Rausei S. Conversion surgery for gastric cancer patients: A review. World J Gastrointest Oncol 2018; 10(11): 398-409
URL: https://www.wjgnet.com/1948-5204/full/v10/i11/398.htm
DOI: https://dx.doi.org/10.4251/wjgo.v10.i11.398

Zurleni T, Gjoni E, Altomare M, Rausei S. Conversion surgery for gastric cancer patients: A review. World J Gastrointest Oncol 2018; 10(11): 398-409 [PMID: 30487951 DOI: 10.4251/wjgo.v10.i11.398]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.